GleanMark

CRISPR THERAPEUTICS Trademark

CRISPR THERAPEUTICS is a USPTO trademark filed by CRISPR Therapeutics AG. Status: Registered.

Trademark Facts

MarkCRISPR THERAPEUTICS
Serial Number98164705
Registration Number7701014
StatusRegistered
Filing Date2023-09-05
Registration Date2025-02-25
Mark TypeCombined
Nice Classes005 (Pharmaceuticals), 041 (Education & Entertainment), 042 (Software & IT)
OwnerCRISPR Therapeutics AG
Attorney of RecordTiffany D. Gehrke
Prosecution Events16
Latest EventR.PR on 2025-02-25

Goods & Services

Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders; "THERAPEUTICS"; Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Related